9159金沙游艺场-金沙9159游艺场手机版-www.9159.com

当前位置: 9159金沙游艺场 > 学术信息 > 正文

学术信息
学术信息
学术讲座通知
来源:9159金沙游艺场科学技术与学科建设处、人才培养处、人力资源处    日期:2013-09-17     浏览次数:
讲座题目
The role(s) of the “Aggrecanases” in cartilage degradation in the pathogenesis of Osteoarthritis.
主讲人
Professor Bruce Caterson
School of Biosciences, Cardiff University, Cardiff, UK.
讲座时间/地点
2013-9-23周一 14:30/9159金沙游艺场公共卫生学院三层会议室
讲座领域
糖生物学、基质代谢
内容概况
In the mid-1990’s the identity of “the Aggrecanases” (i.e. ADAMTS-4 & ADAMTS-5) were first described by researchers at Dupont, USA. Since then there have been numerous studies investigating the unique properties of these two different matrix metalloproteinases that are responsible for aggrecan degradation in the pathogenesis of osteoarthritis (OA) in humans and numerous animal models of the disease. It is clear that both of these “Aggrecanases” can cleave aggrecan in its interglobular domain (IGD) thereby releasing the majority of the glycosaminoglycan containing domains of aggrecan from the cartilage that eventually leads to loss of the cartilage’s physiological function of resisting compressive loading during joint movement; i.e. the degradation of aggrecan by the “Aggrecanases” leads to loss of aggrecan from the cartilage that eventually leads to cartilage fibrillation and eburnation down to the subchondral bone (i.e. joint space narrowing). In spite of the discovery of “the Aggrecanases” now over 15 – 20 years ago, researchers still do not know which of the two “Aggrecanases” (either ADAMTS-4 or -5) is the major contributor to cartilage degradation in the pathogenesis of OA in different animal models of OA and in human patients. Recently, our laboratory discovered a spice-variant of one of the two “Aggrecanases”; the spice-variant of ADAMTS-4 named ADAMTS-4_v1 that is specifically produced in synovial tissue from human OA patients; i.e. this spice-variant is produced only in the synovium and not the cartilage from human OA patients. We believe that this newly discovered synovium-derived “Aggrecanase” is a major contributor to the degradation of aggrecan from the superficial zone of articular cartilage in the early stages of the onset of OA pathology in human patients. These recent findings have provided a new target for pharmaceutical interventions that can be used to slow down the progression of OA in humans.
       Reference: Wainwright SD, Bondeson J, Caterson B & Hughes CE (2013). ADAMTS4_v1 is a splice variant of ADAMTS4 that is expressed as a protein in human synovium and cleaves aggrecan at the interglobular domain. Arthritis Rheum. July 29th (Epub ahead of print).
备注
 
0

上一条:学术报告

下一条:学术讲座通知

  • 交大主页
  • 游艺场信箱
  • 思源BBS
  • 图书馆
  • 思源邮件
  • 信息门户
  • 教师主页

地址:陕西省西安市雁塔西路76号,邮编:710061

版权所有:9159金沙游艺场

www.9159.com

XML 地图 | Sitemap 地图